Adipokines are promising pharmacological treatment targets for obesity and metabolic disorders as they regulate appetite and satiety, energy expenditure, blood pressure, endothelial function, insulin sensitivity, adipogenesis, fat distribution and insulin secretion (7). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.